Glycosa
  • Home
  • Introduction
  • Status of the MVP
  • Strategic Partnerships
  • Current Stages
  • Human Trials and Promise
  • Team
  • Investor Relations
  • More
    • Home
    • Introduction
    • Status of the MVP
    • Strategic Partnerships
    • Current Stages
    • Human Trials and Promise
    • Team
    • Investor Relations
Glycosa
  • Home
  • Introduction
  • Status of the MVP
  • Strategic Partnerships
  • Current Stages
  • Human Trials and Promise
  • Team
  • Investor Relations

Non-Invasive Blood Glucose Monitoring

Revolutionary Technology

  • No needles
  • No pain
  • No consumable part

Based on powerful AI

  • Use of multiple sensors
  • Sampling from different points
  • 3000 calculations per second on average
  • Recognition of the patient’s physical properties in a week to personalize the formulas

Diabetes is a silent killer

Consumer Pain Points – Current Statistics:

  

  • Diabetes has No cure – Only Monitoring and Treatment (Silent Killer).
  • Per WHO - ~422 Million Diabetes patients world-wide and ~1.5 million deaths per year.(1) 
  • Per CDC - One in Ten Americans are Diabetic.(2)  
  • Per CDC – One in Three are Pre-Diabetic.(2)  
  • 8 in 10 adults with prediabetes don’t know they have it.(2) 

  

  

1.https://www.who.int/health-topics/diabetes

2.https://www.cdc.gov/diabetes/library/spotlights/diabetes-facts-stats.html


Glycosa® aims to capture market gap that exists in the non-invasive blood glucose moNITORING SEGMENT

How does our device work?

Our technology

New Optical Bio-sensors

With an innovative combination of several novel optical sensors and multi-layered artificial intelligence with the ability to adapt and personalize, we have been able to create a highly functional and highly accurate device for diabetic patients. We have been testing this technology for more than 2 years in an accredited laboratory with more than 7,000 diabetic patients, improving its accuracy and patenting it in the United States.

Real Bio-Monitoring

By using high-resolution sensors, the blood that passes through the fingertips is continuously monitored, by measuring important blood factors and creating a meaningful relationship between them, blood glucose is calculated with high accuracy with the help of the artificial intelligence of the device. (Patent Pending)

Our superiority over competitors

For the first time in the world

Many companies in the world are looking to realize the dream of non-invasive blood glucose monitoring. Our advantage over competitors is the use of a new combination of sensors with multi-layered artificial intelligence. We have been able to achieve this combination of sensors and artificial intelligence with clinical tests on diabetic patients in two years and patent it.

Getting better and better

Since we use several sensors with different characteristics and different wavelengths,(unlike our competitors), we can also work on other blood factors and effective factors on diabetic patients so in the next steps to create an unrivaled market for our product, so that diabetic patients do not need to use other devices.

  • Home
  • Introduction
  • Status of the MVP
  • Strategic Partnerships
  • Current Stages
  • Human Trials and Promise
  • Team
  • Investor Relations

Copyright © 2024 GLYCOSA - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept